Pricing updated 2015-12-01. Prices are subject to change without notice.
The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-
|Formulation||A crystalline solid|
WARNING - This product is not for human or veterinary use.
|Shipping||Room temperature in continental US; may vary elsewhere|
Download Product Insert 124 Kb PDF
Download Safety Data Sheet (SDS) 27 Kb PDF
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GCMS spectra of many of Caymans emerging forensic drug standards
Separate multiple batch numbers with commas
1. Pertwee, R.G. Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6 635-664 (1999).
2. Martin, B.R., Mechoulam, R., and Razdan, R.K. Discovery and characterization of endogenous cannabinoids. Life Sci 65 573-595 (1999).
Jüttler, E., Potrovita, I., Tarabin, V., et al. The cannabinoid dexanabinol is inhibitor of the nuclear factor-
We offer you the deep and diverse knowledge of more than 100 in-house scientists and the expertise that comes from more than three decades of designing and developing the tools to advance biomedical research.
Cayman is know as a partner to scientists worldwide, responding to your needs with services in: